pd 98059 has been researched along with Pulmonary Arterial Remodeling in 2 studies
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, H | 1 |
| Cheng, Y | 1 |
| Zong, L | 1 |
| Huang, L | 1 |
| Qiao, C | 1 |
| Li, W | 1 |
| Gong, B | 1 |
| Hu, J | 1 |
| Liu, H | 1 |
| Wang, X | 1 |
| Zhao, C | 1 |
| Jing, L | 1 |
| Zhang, J | 1 |
| Sun, J | 1 |
| Guo, F | 1 |
| An, X | 1 |
| Yang, K | 1 |
| Li, PA | 1 |
2 other studies available for pd 98059 and Pulmonary Arterial Remodeling
| Article | Year |
|---|---|
Aspirin attenuates monocrotaline-induced pulmonary arterial hypertension in rats by suppressing the ERK/MAPK pathway.
Topics: Animals; Aspirin; Blood Pressure; Cyclooxygenase Inhibitors; Flavonoids; Hypertension, Pulmonary; Hy | 2017 |
Inhibition of extracellular signal-regulated kinases ameliorates hypertension-induced renal vascular remodeling in rat models.
Topics: Animals; Endothelium, Vascular; Female; Flavonoids; Hypertension; Male; MAP Kinase Signaling System; | 2011 |